New patent legislation introduced in US, offers industry “greater predictability”
This article was originally published in Clinica
Executive Summary
US Senator John Kyl has introduced a new patent reform bill, the Patent Reform Act (S3600), into the Senate this week after previous proposals for reforming the system raised strong objections from medtech and pharmaceutical companies. The new bill has been welcomed by the healthcare industry as a vast improvement on the legislative proposals currently pending in the House and Senate.